Patients with moderate SSDAI scores more frequently had positive biopsies of MSG (p = 0.015), positive anti-SSB (p = 0.033), concurrent therapy of corticosteroids (p = 0.019) and higher US activity (p = 0.01) compared to those of pSS patients with low disease activity. The gene discussed is SSB; the disease is peeling skin syndrome.